(Q81831688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15946580%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Unique issues in the development of "targeted" antineoplastic pharmaceutical agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15946580%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Maurie Markman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15946580%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15946580%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

published in

Current Oncology Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15946580%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15946580%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15946580%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

235-236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15946580%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11912-005-0043-8

12 January 2020

exact match

0 references

cites work

Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

1 reference

12 December 2020

STI571: a paradigm of new agents for cancer therapeutics

1 reference

12 December 2020

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

12 December 2020

Targeting the epidermal growth factor receptor in non-small cell lung cancer.

1 reference

12 December 2020

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung

1 reference

12 December 2020

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

1 reference

12 December 2020

Severe acute interstitial pneumonia and gefitinib

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

12 December 2020

Pharmacogenomics. Cancer sharpshooters rely on DNA tests for a better aim.

1 reference

12 December 2020